Literature DB >> 25243055

Pathogenesis of Osteoporosis.

Sundeep Khosla1.   

Abstract

As for most multifactorial disorders, the pathogenesis of osteoporosis is complex, and a different set of mechanisms may be operative in any given individual. However, there are certain common causes of bone loss and increased fracture risk with aging in most people. These include genetic factors contributing to the acquisition of peak bone mass, illnesses affecting skeletal growth and development, sex steroid deficiency following the menopause in women and with aging in men, and intrinsic, age-related changes in bone metabolism. Superimposed on these factors are specific secondary causes of bone loss, such as corticosteroid use or other illnesses affecting bone metabolism that may contribute to fracture risk in individuals exposed to these factors. The past decade has witnessed tremendous advances in our understanding of each of these various causes of bone loss, leading to the development of novel, mechanism-based therapeutic approaches to prevent and treat this important public health disorder.

Entities:  

Keywords:  bone loss; fractures; osteoporosis

Year:  2010        PMID: 25243055      PMCID: PMC4167368          DOI: 10.1210/TEAM.9781879225718.ch2

Source DB:  PubMed          Journal:  Transl Endocrinol Metab        ISSN: 1948-9544


  116 in total

1.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  FSH directly regulates bone mass.

Authors:  Li Sun; Yuanzhen Peng; Allison C Sharrow; Jameel Iqbal; Zhiyuan Zhang; Dionysios J Papachristou; Samir Zaidi; Ling-Ling Zhu; Beatrice B Yaroslavskiy; Hang Zhou; Alberta Zallone; M Ram Sairam; T Rajendra Kumar; Wei Bo; Jonathan Braun; Luis Cardoso-Landa; Mitchell B Schaffler; Baljit S Moonga; Harry C Blair; Mone Zaidi
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 4.  Clinical review 144: Estrogen and the male skeleton.

Authors:  Sundeep Khosla; L Joseph Melton; B Lawrence Riggs
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

5.  Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2.

Authors:  C H Kasperk; K Faehling; I Börcsök; R Ziegler
Journal:  Calcif Tissue Int       Date:  1996-05       Impact factor: 4.333

6.  Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Authors:  P Garnero; E Sornay-Rendu; M C Chapuy; P D Delmas
Journal:  J Bone Miner Res       Date:  1996-03       Impact factor: 6.741

7.  Production and characterization of an antibody against the human bone GLA protein (BGP/osteocalcin) propeptide and its use in immunocytochemistry of bone cells.

Authors:  R Kasai; P Bianco; P G Robey; A J Kahn
Journal:  Bone Miner       Date:  1994-06

8.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

9.  Epidemiology of fractures of the distal end of the radius in children as associated with growth.

Authors:  D A Bailey; J H Wedge; R G McCulloch; A D Martin; S C Bernhardson
Journal:  J Bone Joint Surg Am       Date:  1989-09       Impact factor: 5.284

10.  A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men.

Authors:  B Lawrence Riggs; L Joseph Melton; Richard A Robb; Jon J Camp; Elizabeth J Atkinson; Lisa McDaniel; Shreyasee Amin; Peggy A Rouleau; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2008-02       Impact factor: 6.741

View more
  6 in total

Review 1.  Drug discovery of sclerostin inhibitors.

Authors:  Sifan Yu; Dijie Li; Ning Zhang; Shuaijian Ni; Meiheng Sun; Luyao Wang; Huan Xiao; Dingdong Liu; Jin Liu; Yuanyuan Yu; Zongkang Zhang; Samuel Tin Yui Yeung; Shu Zhang; Aiping Lu; Zhenlin Zhang; Baoting Zhang; Ge Zhang
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

Review 2.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

3.  Immunoexpression pattern of autophagy mediators in alveolar bone osteoclasts following estrogen withdrawal in female rats.

Authors:  Rinaldo Florencio-Silva; Gisela Rodrigues da Silva Sasso; Estela Sasso-Cerri; Manuel de Jesus Simões; Paulo Sérgio Cerri
Journal:  J Mol Histol       Date:  2021-01-06       Impact factor: 2.611

4.  Effects of testosterone and 17β-estradiol on osteogenic and adipogenic differentiation capacity of human bone-derived mesenchymal stromal cells of postmenopausal women.

Authors:  Kristina Glenske; Gerhard Schuler; Stefan Arnhold; Mohamed I Elashry; Alena-Svenja Wagner; Mike Barbeck; Elena Neumann; Ulf Müller-Ladner; Reinhard Schnettler; Sabine Wenisch
Journal:  Bone Rep       Date:  2019-10-21

5.  U.S. Montmorency Tart Cherry Juice Decreases Bone Resorption in Women Aged 65-80 Years.

Authors:  Tiffany Dodier; Kendall L Anderson; James Bothwell; Janice Hermann; Edralin A Lucas; Brenda J Smith
Journal:  Nutrients       Date:  2021-02-07       Impact factor: 5.717

6.  Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648.

Authors:  Zhang Min; Liu Xiaomeng; Li Zheng; Du Yangge; Liu Xuejiao; Lv Longwei; Zhang Xiao; Liu Yunsong; Zhang Ping; Zhou Yongsheng
Journal:  Cell Death Dis       Date:  2019-08-05       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.